Social risk burden among U.S. cancer survivors across adulthood: Evidence from the 2022-2023 BRFSS.
This publication uses 2022–2023 Behavioral Risk Factor Surveillance System data (over 470,000 respondents, representin...
Preventing obesity-related cancer with the revolution in obesity management: the challenges of undertaking a clinical trial and potential solutions.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication is a perspective piece examining whether modern anti-obesity pharmacotherapy—particularly GLP‑1 rec...
Alcohol use disorder: an Australian perspective on screening, diagnosis, treatment and prevention.
- Post category:Supportive Oncology
- Reading time:2 mins read
This article reviews the burden of alcohol-related harm in Australia and highlights major gaps in policy and clinical pr...
Leveraging Artificial Intelligence and Large Language Models for Cancer Immunotherapy.
- Post category:Supportive Oncology
- Reading time:3 mins read
This publication is a narrative review of how artificial intelligence and machine learning are being applied to advance...
Cardiotoxicity of T cell immunotherapies.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication is a narrative review focused on cardiovascular complications associated with T cell–based cancer imm...
Integrating germline and tumor sequencing to improve hereditary cancer diagnosis and care.
- Post category:Supportive Oncology
- Reading time:2 mins read
This review focuses on how tumor genomic features can be leveraged to better diagnose, classify, and treat hereditary ca...